- Filed
- Mar 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 1.26M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 1.26M sh |
| Capex | FY 2025 · Dec 31, 2025 | $16K |
| Capex | FY 2025 · Dec 31, 2024 | $146K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$20.45M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$24.67M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $8.67M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $9.99M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $18.59M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $38.39M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $64.9M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $4.25M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $5.45M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $4.31M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $6.98M |
| Current Assets | FY 2025 · Dec 31, 2025 | $21.51M |
| Current Assets | FY 2025 · Dec 31, 2024 | $41.93M |
| Total Assets | FY 2025 · Dec 31, 2025 | $22.9M |
| Total Assets | FY 2025 · Dec 31, 2024 | $45.36M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$16.72 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$24.01 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$16.72 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$24.01 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $11.33M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $13.04M |
| Net Income | FY 2025 · Dec 31, 2025 | −$21.09M |
| Net Income | FY 2025 · Dec 31, 2024 | −$30.16M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$22.29M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$32.61M |